Press Release
Rapid application design service enables executives to visualize scenarios and products
San Mateo, CA - January 20, 2010 - Catalyst Resources, the global leader in Rich Internet Application (RIA) design for mission critical applications, today announced their work with Roche, the world’s leading research-focused health care diagnostics group, to rapidly define product concepts for online diagnostic collaboration solutions using the latest RIA technologies.
The rapid design project enabled executives and healthcare professionals to visualize how a sophisticated RIA could leverage Roche technologies and enable real-time collaboration and analysis by clinical staff of advanced diagnostic activities, all within a secure and scalable environment.
Catalyst developed the prototype using a user interface/RIA swat team consisting of an on-site designer working with a distributed team of off-site developers and application architects.
By bridging Roche on-line and off-line medical services together in one place for medical information sharing, the Catalyst prototypes helped Roche identify service scenarios and visualize products that would cost-effectively improve the effectiveness of diagnosis, medical consultations and even patient education.
About Catalyst Resources
Catalyst specializes in the unique demands of scalable, modular and reusable UI for Software as a Service (SaaS), Healthcare, financial services and Rich Internet Application design. Since 1994, Catalyst Resources has successfully delivered user interface design for more than 300 mission critical software applications to leading global firms including ADP, Applied Biosystems, Cisco, HP, InterCall, Leukemia Society, SAP, and Ventana Medical. Headquartered in the Silicon Valley, Catalyst Resources employs accomplished UI designers, information architects, developers and business professionals. More information about Catalyst Resources can be found at www.catalystresources.com.
About Roche
Headquartered in Basel, Switzerland, Roche is one of the world’s leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics. As the world’s biggest biotech company and an innovator of products and services for the early detection, prevention, diagnosis and treatment of diseases, the Group contributes on a broad range of fronts to improving people’s health and quality of life. Roche is the world leader in in-vitro diagnostics and drugs for cancer and transplantation, and is a market leader in virology. It is also active in other major therapeutic areas such as autoimmune diseases, inflammatory and metabolic disorders and diseases of the central nervous system. Worldwide, the Group employs about 80,000 people. Additional information is available on the Internet at www.roche.com.